Medicine and Dentistry
Prospective Study
88%
Lipoatrophy
44%
Nevirapine
44%
Bootstrapping
44%
Headache
44%
Low Back Pain
44%
Polyacrylamide Gel
44%
Effect Size
44%
HIV Type 1
44%
Surgery
44%
Interdisciplinary Care
44%
Logistic Regression Analysis
44%
Medicare
44%
Neurotoxicity
44%
Fetal Surgery
44%
Human Immunodeficiency Virus
37%
Polylactic Acid
33%
Quality of Life
33%
Polyacrylamide
22%
Patient Satisfaction
22%
Adverse Event
20%
High Density Lipoprotein Cholesterol
17%
Drug Megadose
14%
Uterus Relaxation
14%
Reactive Attachment Disorder
11%
Emotion
11%
Photograph
11%
Lipodystrophy
11%
Liver Toxicity
8%
Highly Active Antiretroviral Therapy
8%
Surgical Technique
7%
Cognitive Defect
7%
Anesthetic Agent
7%
Brain Development
7%
Human Subject
7%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Prospective Study
88%
Nevirapine
50%
Lipoatrophy
44%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
44%
Dyslipidemia
44%
Low Back Pain
44%
Headache
44%
Ezetimibe
44%
Antilipemic Agent
44%
Polyacrylamide Gel
44%
Neurotoxicity
44%
Polylactic Acid
33%
High Density Lipoprotein Cholesterol
30%
Pravastatin
25%
Low Density Lipoprotein Cholesterol
25%
Polyacrylamide
22%
Adverse Event
20%
Cmin
12%
Nonnucleoside Reverse Transcriptase Inhibitor
12%
Pharmacokinetics
12%
Proteinase Inhibitor
12%
Lipodystrophy
11%
Psychosocial Disorder
11%
Anesthetic Agent
11%
Cognitive Defect
11%
Preclinical Study
11%
Homo sapiens
11%
Hepatotoxicity
8%
Tolerability
6%
C Reactive Protein
6%
CYP3A4
6%
Lopinavir
6%
Triacylglycerol
6%
Creatinine
6%
Statin (Protein)
6%
Apolipoprotein A
6%
Liver Enzyme
6%
Phosphotransferase
6%
Apoprotein
6%
Cytochrome
6%
Low Density Lipoprotein
6%
Keyphrases
Long-term Safety
44%
Long-term Efficacy
44%
Human Immunodeficiency Virus Type 1 (HIV-1)
44%
Synthetic Substances
44%
Infected Patients
44%
Nevirapine
44%
Anesthetic Neurotoxicity
44%
Fetal Surgery
44%
Brain Development
44%
General Anesthetics
35%
Acid Gel
33%
HIV Patients
17%
LDL Cholesterol
17%
Cholesterol Levels
17%
Uterine Relaxation
17%
Anesthetic Techniques
17%
High Dose
17%
Viral
8%
HIV RNA
8%
Liver Toxicity
8%
RNA Load
8%
Treatment-naïve
8%
Observation Study
8%
Highly Active Antiretroviral Therapy (HAART)
8%
Adverse Events
8%
Metabolic Profiling
8%
Viral Suppression
8%
AST-ALT
8%
Open Fetal Surgery
8%
Fetal Exposure
8%
Anesthesia
8%
Surgical Procedures
8%
Significant Risk Factors
8%
Safer Alternatives
8%
Human Subjects
8%
Developmental Neurotoxicity
8%
Neurotoxic Effects
8%
Anesthetic Agents
8%
Primates
8%
Surgical Conditions
8%
Anesthesia Care
8%
Cognitive Deficits
8%
Development Impacts
8%
Surgical Access
8%
Anesthetic Exposure
8%
Neurotoxicity
8%
Rodents
8%
Clinical Setting
8%
Neurological Deficit
8%
Homocystein
6%
